Ori Biotech Cell & Gene Tech Expo April 2025: Cell Therapy

Oribiotech is a London and Philadelphia-based manufacturing technology company on a mission to enable widespread patient access to life-saving cell and gene therapies. IRO®, Ori’s next-generation manufacturing platform automates better biology, accelerates product development and enables therapy developers to scale their products’ clinical and commercial impact by seamlessly transitioning from R&D to GMP on one platform. The promise of the innovative Ori platform is to automate cell therapy manufacturing, increasing throughput, improving quality and decreasing costs by combining proprietary hardware, consumables, software, data and analytics.

Tom Heathman, Chief Commercial Officer at Oribiotech, shares details about the IRO platform and how this new standard is re-thinking cell and gene manufacturing to enable widespread patient access.